Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - BridgeBio Pharma, Inc. | StockGist | StockGist

Companies
BBIO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings BBIOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

BridgeBio Pharma, Inc.

Filed Feb 13, 2025

Accepted Feb 12, 2025, 7:00 PM ET

CIK 0001743881

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

211,718

Reporting Person

BridgeBio Pharma, Inc.

Person Type

IN

CUSIP: 10806X102

Amendment History

3 filings

SCHEDULE 13G
Original
Nov 14, 20250000080255-25-000848
SCHEDULE 13G/A
Amendment 1
Viewing
Feb 13, 20250000950170-25-020045
SCHEDULE 13G/A
Amendment 2
Latest
Jul 29, 20250000932471-25-000753

Key Facts

Shares Owned

211,718

Recent Filings

BridgeBio Pharma, Inc.4 days ago

BridgeBio Pharma, Inc.1 weeks ago

BridgeBio Pharma, Inc.1 months ago

BridgeBio Pharma, Inc.1 months ago

BridgeBio Pharma, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice